Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose Ranging Study of Dialysate Containing Soluble Ferric Pyrophosphate (SFP) Versus Control in Subjects With ESRD Receiving Chronic Hemodialysis.

NCT00548249 is registered in ClinicalTrials.gov with Rockwell Medical Technologies, Inc. as lead sponsor.

NCT NCT00548249
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00548249 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose Ranging Study of Dialysate Containing Soluble Ferric Pyrophosphate (SFP) Versus Control in Subjects With ESRD Receiving Chronic Hemodialysis.
Lead sponsor
Rockwell Medical Technologies, Inc.
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2007
Completion date
January 31, 2010
Enrollment
131 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

end-stage renal disease (esrd)